National Consortium of Breast Centers 34th Annual Interdisciplinary Breast Center Conference 2025

1. Overview
The National Consortium of Breast Centers 34th Annual Interdisciplinary Breast Center Conference 2025 provides an advanced clinical and operational review for comprehensive breast care. The program highlights innovations in genetic testing, high-risk patient management, treatment de-escalation strategies, patient navigation, and the integration of AI to enhance overall quality and patient experience in modern breast centers.
Course Date: June 21-23, 2025
2. Learning Objectives

Evaluate complex genetic variations, including TP53 mutations, and apply updated guidelines for variant reclassification and panel testing.

Implement targeted, personalized treatment strategies for high-risk breast lesions and special populations to optimize clinical outcomes.

Assess the viability of de-escalation techniques, such as cryoablation, and novel risk-reducing therapies in comprehensive breast cancer care.

Integrate artificial intelligence tools to streamline outcomes reporting, enhance quality metrics, and improve the overall patient experience.

Develop multidisciplinary navigation programs that effectively address financial toxicity, psychological well-being, and fertility preservation disparities.

3. Target Audience

Best for breast surgeons and oncologists who want updates on high-risk lesions, genetic testing, and personalized breast care strategies.

4. Topics

AI to Enhance Patient Experience and Quality Reportables

Beyond Breast Cancer Risk Advancing the 3 Ps of Breast Cancer Care- Personalized Precision and Patient-Centered

Clinical Trials Navigation

Complexities of Interpretation of a TP53 Pathogenic or Likely Pathogenic Variants PLP

De-escalation of Treatment- Is Cryoablation the Answer

Disparities in Fertility Preservation for Breast Cancer Patients and Genetic Mutation Carriers Where Are We Now

Exploring the Complexities of High-Risk Breast Lesions

Exploring the Nuances of Update Panel Testing and Variant Reclassification

Focusing in on High-Risk Care for Special Populations

Future Directions Overcoming Barriers to Care for the High-Risk Patient

Genetic Testing for Some or for All

Granulomatous Mastitis with Targeted Intralesional Steroid Injections

Impact Award Winner Announced by Dr Jennifer Plichta Award Winner Presentation- A Road Less Traveled Advocating for…

Inspiration Award Recognition with Dr Cary Kaufman Certification Recognition with Dr Kristie Bobolis Nicole Centers

Interactive Case Discussion 1

Interactive Case Discussion 2

Keynote Living the Boobie Queen Life Addressing Mental Health After Breast Cancer

Kids Need Navigation Too

Long Term Effects of Treatments on the Pelvic Floor

Managing the New Spectrum of HR Disease High 1 and High 2

Measuring Moments for Outcomes Reporting

Navigating the Line Between Support and Over-Extension

New Insights for Use of Hormones the High-Risk Patient

Past Present and Future of Clinical Trials for High-Risk and Hereditary Cancer Syndromes

Psychological Impact of Breast Cancer Identification Treatment and Quality of Life

Removing Toxic from Finances

The Big Little R – Research in the Community Setting

The Future of Utilizing Cancer Risk Assessment Models

The Impact of Breast Cancer Treatments on Cardiac Health

The Journey Shining a Light on Male Breast Cancer

Touchpoints in Navigation

Understanding New Directions in Risk Reducing Therapies

Understanding the Why of Imaging Options

Updates on Lymphedema Management

What is on the Horizon for Polygenic Risk Score

What Will You Do on Monday

Why Does It Look This Way